BIO-Europe Spring 2015: Interview with Kunihiko Suzuki, Medinet

July 7, 2015
Immunotherapy promises to transform healthcare, but is slowed by limited access to affordable materials, know-how and development facilities. Kunihiko Suzuki of Medinet discusses the ways in which his company is helping to break this bottleneck for companies worldwide. Find more videos and articles at http://www.partnering360.com/insight. For more information on BIO-Europe Spring, visit our webpage: http://www.ebdgroup.com/bes/index.php
Previous Video
BIO-Europe Spring 2015: Interview with Yoshihide Esaki, METI
BIO-Europe Spring 2015: Interview with Yoshihide Esaki, METI

Regenerative medicine is big in Japan. Yoshihide Esaki of METI discusses how his organization is working wi...

Next Video
BIO-Europe Spring 2015: Interview with Angele Maki, Genentech
BIO-Europe Spring 2015: Interview with Angele Maki, Genentech

Genentech is striking bold moves into whole genome sequencing. Angele Maki of Genentech discusses the strat...